what's the difference between tirzepatide and zepbound Zepbound® Weight Loss Program Zepbound® Weight Loss Program |
Description
The weight loss drug semaglutide will be made available for prescription from 4 September 2023, in what its manufacturer, Novo Nordisk, has described as a controlled and limited launch of the drug
Tirzepatide dosing follows a careful escalation schedule designed to maximize weight loss while minimizing nausea and gastrointestinal side effects
Free doctor consultation and home delivery.
Pharmacologic therapies, while more broadly accessible and less invasive, typically yield more modest reductions in visceral adiposity
It is the first GLP-1 pill approved for losing excess weight.
